Edward Neuberger is an experienced professional in the pharmaceutical industry, currently serving as a Director at Pfizer since November 2024, following a tenure as a Senior Manager at the same organization from January to November 2024. Prior roles include Senior Manager at Seagen from November 2021 to December 2023 and a Post-doctoral Fellow in Health Economics and Outcomes Research at Genentech from July 2018 to April 2020, where collaboration with The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute at the University of Washington took place. Edward has contributed to significant projects involving various pharmaceutical products, including Esbriet and Xolair, and has previously held roles at BluePeak Advisors and the University of Maryland Medical Center. Edward holds a Doctor of Pharmacy (PharmD) from the University of Maryland School of Pharmacy, a Master of Science in Pharmaceutical Outcomes Research and Policy from the University of Washington, and an MBA from the University of Baltimore Merrick School of Business.
This person is not in any teams
This person is not in any offices